BMP-8 inhibitors belong to a specific chemical class that encompasses a group of compounds known for their ability to modulate the activity of bone morphogenetic protein 8 (BMP-8). BMP-8 is a member of the transforming growth factor beta (TGF-β) superfamily, which plays crucial roles in various biological processes, particularly in the regulation of bone and cartilage development, as well as tissue homeostasis. BMP-8 inhibitors are designed to specifically interact with BMP-8 molecules and interfere with their normal signaling pathways. These inhibitors typically possess unique structural features that enable them to bind to BMP-8 and hinder its binding to its receptors, thereby impeding the downstream signaling cascade. By blocking the interaction between BMP-8 and its receptors, these inhibitors disrupt the transmission of cellular signals that are typically initiated by BMP-8. This modulation of BMP-8 activity can have far-reaching effects on multiple cellular processes, as BMP-8 is involved in diverse physiological functions, including embryonic development, tissue regeneration, and cellular differentiation.
BMP-8 inhibitors are designed to be selective and exhibit high affinity for BMP-8, allowing them to specifically target this protein without interfering with the function of other members of the TGF-β superfamily. The structural characteristics of these inhibitors may vary, ranging from small molecules to larger compounds, depending on the specific chemical design. Researchers employ a variety of synthetic and computational approaches to develop novel BMP-8 inhibitors with enhanced potency, specificity, and pharmacokinetic properties. Through their ability to modulate BMP-8 signaling, these inhibitors provide valuable tools for investigating the biological roles of BMP-8 in various contexts. They serve as important research reagents to dissect the intricate mechanisms underlying BMP-8-mediated cellular processes, contributing to a deeper understanding of the fundamental biology associated with BMP-8. The development and utilization of BMP-8 inhibitors pave the way for advancements in the field of molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $213.00 $318.00 $632.00 $1047.00 | 2 | |
DMH1 is a selective small molecule inhibitor of BMP signaling that has been shown to block the activity of multiple BMP ligands, including BMP-8. | ||||||
5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | 1432597-26-6 | sc-476318 | 5 mg | $380.00 | ||
LDN-212854 is a newer compound that has been developed as a BMP signaling inhibitor, but specific information about its activity against BMP-8 is limited. | ||||||